spacer.png, 0 kB
Search
Trilogy Writing & Consulting GmbH

Trilogy Writing & Consulting GmbH

Trilogy Writing & Consulting GmbH

Trilogy Writing & Consulting GmbH
Falkensteiner Str 77
60322 Frankfurt
Germany
Email: writers@trilogywriting.com
Web: www.trilogywriting.com
Title: Business Development Manager
First Name: Evija
Last Name: Kümmel
Phone: +49(0) 69 138 2528-22
Fax: +49(0) 69 138 2528-55
Skills And Services Offered:

Trilogy is focused entirely on medical writing and medical writing training, offering the full range of regulatory clinical documentation across all therapeutic areas.

Trilogy provides “best of breed” Medical Writing with an in-depth understanding of regulatory documentation and the expertise necessary to crystallize the ultimate messages. This ensures a quality that minimizes the time for authority review and approval.

We pride ourselves on our “dedicated team” approach when developing documents, which greatly reduces the time needed for production and ensures much greater levels of continuity throughout an entire development programme. Concretely, we offer a very high speed of turn-around, which may be crucial to reducing the time to market.

Trilogy Portfolio overview of Clinical Documentation

ASR Annual Safety Report
CDP Clinical Development Plan
CSP Clinical Study Protocol
CSR Clinical Study Report
CTD Common Technical Document
CTR Clinical Trial Report
IB Investigator‘s Brochure
ICF Informed Consent Form
IMPD Investigational Medicinal Product Dossier
IND Investigational New Drug
PI Product Information
PIP Paediatric Investigation Plan
PSUR Periodic Safety Update Report
RMP Risk Management Plan
SmPC Summary of Product Characteristics
USPI United States Prescribing Information

Expertise:

We have written documents in the following Therapeutic Areas:

Anti-infectives Oncology
Behavioural health Paediatrics
Blood products/haematology Respiratory
Cardiology Rheumatology
Dermatology Skeletal disease
Endocrinology/metabolism Urology
Immunology Vaccines
Neurology/ Central Nervous System Women‘s Health/ Gynaecology
Ophthalmology  

..and in the following Development Areas:

Phase 1, 2, 3 and 4 Pharmacodynamics (PD)
All Types of Submissions Biotech
Responses to Authorities Biologics
Agency Hearings / Meetings Devices
Pharmacokinetics (PK) Orphan Drugs

Other Information:

Please, visit our website for additional information, including three short videos by the founding partners, which give an idea of the style and philosophy of Trilogy.


Date added: 2007-9-13 20:27:00   
Powered by Sigsiu.NET RSS Feeds
spacer.png, 0 kB